<DOC>
	<DOC>NCT02987907</DOC>
	<brief_summary>The current random, double-blind, controlled, clinical trial was designed to evaluate the impact on therapeutic effect and tolerance of treatment for patients with hepatocelluclar carcinoma in transcatheter arterial chemoembolization (TACE) of dexamethasone application.</brief_summary>
	<brief_title>The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial.</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>older than 18 years old; ECOG PS&lt;3; proven hepatocellular carcinoma according patological examination or EASL/AASLD diagnostic criteria; meeting at least 1/4: 1) multiple nodules, 2) single tumor but not suitable for resection, 3) vascular invasion exists, 4) distant metastasis excluding CNS and bone not previous treated for tumor; ChildPugh A or B; at least one measurable lesion according mRECIST; cannot afford sorafenib; the lab test could meet: neutrophil count≥1.5×109/L; hemoglobin≥80g/L; platelet count≥60×109/L; serum albumin≥28g/L; total bilirubin&lt;3times upper limit of normal; ALT&lt;5times upper limit of normal; AST&lt;5times upper limit of normal; serum creatine&lt;1.5times upper limit of normal; PT≤upper limit of normal plus 6 seconds; INR≤2.3 sign up consent; unrolled by other clinical trials about hepatocellular carcinoma. cannot tolerate TACE; CNS or bone metastasis exits; known history of other malignancy; be allergic to related drugs; underwent organ transplantation before; be treated before (interferon included); known history of HIV infection; known history of drug or alcohol abuse; have GI hemorrage or cardiac/brain vascular events within 30 days; pregnancy;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>